Chevy Chase Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Sell |
71,838
-2,241
| -3% | -$558K | 0.05% | 305 |
|
|
2025
Q4 | $17.8M | Sell |
74,079
-714
| -1% | -$183K | 0.05% | 294 |
|
|
2025
Q3 | $20.5M | Sell |
74,793
-2,725
| -4% | -$744K | 0.06% | 266 |
|
|
2025
Q2 | $20M | Buy |
77,518
+456
| +0.6% | +$109K | 0.06% | 266 |
|
|
2025
Q1 | $17.3M | Sell |
77,062
-85
| -0.1% | -$19.8K | 0.06% | 285 |
|
|
2024
Q4 | $17.6M | Sell |
77,147
-1,752
| -2% | -$422K | 0.05% | 282 |
|
|
2024
Q3 | $19.3M | Sell |
78,899
-1,424
| -2% | -$318K | 0.06% | 274 |
|
|
2024
Q2 | $15.4M | Sell |
80,323
-1,162
| -1% | -$236K | 0.05% | 309 |
|
|
2024
Q1 | $16.1M | Sell |
81,485
-719
| -0.9% | -$132K | 0.05% | 303 |
|
|
2023
Q4 | $14.1M | Sell |
82,204
-423
| -0.5% | -$65K | 0.05% | 316 |
|
|
2023
Q3 | $12.2M | Sell |
82,627
-1,937
| -2% | -$350K | 0.05% | 321 |
|
|
2023
Q2 | $18.5M | Sell |
84,564
-845
| -1% | -$188K | 0.07% | 255 |
|
|
2023
Q1 | $18.7M | Buy |
85,409
+1,122
| +1% | +$243K | 0.07% | 249 |
|
|
2022
Q4 | $17.5M | Sell |
84,287
-5,159
| -6% | -$1.13M | 0.07% | 254 |
|
|
2022
Q3 | $19.5M | Buy |
89,446
+1,067
| +1% | +$243K | 0.08% | 223 |
|
|
2022
Q2 | $18.5M | Buy |
88,379
+411
| +0.5% | +$87.5K | 0.08% | 240 |
|
|
2022
Q1 | $21.3M | Buy |
87,968
+539
| +0.6% | +$130K | 0.07% | 244 |
|
|
2021
Q4 | $22.8M | Sell |
87,429
-1,954
| -2% | -$507K | 0.07% | 240 |
|
|
2021
Q3 | $23.6M | Sell |
89,383
-3,380
| -4% | -$924K | 0.08% | 222 |
|
|
2021
Q2 | $22.9M | Sell |
92,763
-4,931
| -5% | -$1.04M | 0.08% | 233 |
|
|
2021
Q1 | $19M | Sell |
97,694
-6,751
| -6% | -$1.35M | 0.07% | 274 |
|
|
2020
Q4 | $22.2M | Sell |
104,445
-3,141
| -3% | -$626K | 0.08% | 239 |
|
|
2020
Q3 | $18.4M | Sell |
107,586
-8,970
| -8% | -$1.66M | 0.07% | 252 |
|
|
2020
Q2 | $22.4M | Sell |
116,556
-5,797
| -5% | -$948K | 0.09% | 205 |
|
|
2020
Q1 | $18M | Buy |
122,353
+1,987
| +2% | +$316K | 0.08% | 227 |
|
|
2019
Q4 | $18.7M | Buy |
120,366
+173
| +0.1% | +$24.9K | 0.07% | 279 |
|
|
2019
Q3 | $16.2M | Buy |
120,193
+281
| +0.2% | +$36.8K | 0.07% | 296 |
|
|
2019
Q2 | $14.6M | Buy |
119,912
+200
| +0.2% | +$22.2K | 0.06% | 319 |
|
|
2019
Q1 | $12.5M | Buy |
119,712
+1,913
| +2% | +$197K | 0.05% | 349 |
|
|
2018
Q4 | $13.4M | Buy |
117,799
+422
| +0.4% | +$45.2K | 0.07% | 289 |
|
|
2018
Q3 | $13.5M | Sell |
117,377
-2,899
| -2% | -$318K | 0.06% | 335 |
|
|
2018
Q2 | $12.5M | Sell |
120,276
-718
| -0.6% | -$72.6K | 0.05% | 356 |
|
|
2018
Q1 | $11.9M | Sell |
120,994
-2,152
| -2% | -$203K | 0.05% | 371 |
|
|
2017
Q4 | $10.4M | Sell |
123,146
-1,102
| -0.9% | -$91K | 0.04% | 408 |
|
|
2017
Q3 | $9.56M | Buy |
+124,248
| New | +$9.5M | 0.04% | 412 |
|
Other funds holding RMD
VCM
VPM
DAM
Chevy Chase Trust's RMD Position: Q1 2026 in Review
Chevy Chase Trust reduced its ResMed (RMD) stake by 3% in Q1 2026, selling an estimated $558K and leaving 71,838 shares worth $16.1M. The position accounts for 0.05% of the portfolio, ranked #305.
Chevy Chase Trust first reported a position in RMD in Q3 2017 and has held it in 35 quarters since. The position peaked at $23.6M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Chevy Chase Trust held 71,838 shares of ResMed worth $16.1M as of Q1 2026.
- Chevy Chase Trust sold 2,241 ResMed shares in Q1 2026, an estimated $558K.
- ResMed made up 0.05% of Chevy Chase Trust's portfolio in Q1 2026, its #305 holding.
- Chevy Chase Trust first reported a position in ResMed in Q3 2017 and has held it in 35 quarters since.
- Chevy Chase Trust's ResMed position peaked at $23.6M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.